Tacrolimus Cream

Designed to alleviate atopic dermatitis, utilized to target inflammation and to support to manage compromised skin barrier function.

Strengths: 0.03 · 0.1%

Medicine details

Alternative names

Protopic

Therapeutic class

Calcineurin inhibitor

Pharmacological class

Immunosuppressant

Contraindications

hypersensitivity to tacrolimus; netherton syndrome

Precautions and warnings

minimize sunlight exposure; do not apply to infected skin

Minor side effects

application site irritation; pruritus

Moderate side effects

folliculitis; skin infections

Serious side effects

malignancy — requires immediate medical attention

Dosage forms

Cream

Administration route

Cutaneous use

Prescription status

POM

Manufacturer

Leo Laboratories

Onset Time

1 week

Duration

As directed by physician

Storage instructions

Store below 25°C.

Age restrictions

Not for children under 2 years.

Patient summary

Designed to alleviate atopic dermatitis, utilized to target inflammation and to support to manage compromised skin barrier function.

Mechanism of action

Tacrolimus binds to the cytosolic protein FKBP-12, forming a complex that inhibits calcineurin. This inhibits the activation of T-cells and the subsequent release of inflammatory cytokines.

Pregnancy and breastfeeding

Pregnancy: Use only if clearly necessary. Breastfeeding: Monitor usage carefully.

Tacrolimus Cream

Designed to alleviate atopic dermatitis, utilized to target inflammation and to support to manage compromised skin barrier function.

Editorial Notes

  • Active ingredient(s): Tacrolimus
  • Listed indication(s): Atopic Dermatitis

Available option

  • 3 tubes - 0.1 %1197-0-1-pct-14163